Original Article

International Journal of Obesity (2013) 37, 16–23; doi:10.1038/ijo.2012.132; published online 21 August 2012

Infant antibiotic exposures and early-life body mass

L Trasande1,2,3, J Blustein3,4, M Liu2, E Corwin3, L M Cox5 and M J Blaser4,5

  1. 1Department of Pediatrics, New York University School of Medicine, New York, NY, USA
  2. 2Department of Environmental Medicine, New York University School of Medicine, New York, NY, USA
  3. 3New York University Wagner School of Public Service, New York, NY, USA
  4. 4Department of Medicine, New York University School of Medicine, New York, NY, USA
  5. 5Department of Microbiology, New York University School of Medicine, New York, NY, USA

Correspondence: Dr L Trasande, Department of Pediatrics, New York University, 227 East 30th Street, Room 711, New York, NY 10016, USA. E-mail: Leonardo.trasande@nyumc.org

Received 12 June 2012; Revised 12 July 2012; Accepted 13 July 2012
Advance online publication 21 August 2012

Top

Abstract

Objectives:

 

To examine the associations of antibiotic exposures during the first 2 years of life and the development of body mass over the first 7 years of life.

Design:

 

Longitudinal birth cohort study.

Subjects:

 

A total of 11532 children born at greater than or equal to2500g in the Avon Longitudinal Study of Parents and Children (ALSPAC), a population-based study of children born in Avon, UK in 1991–1992.

Measurements:

 

Exposures to antibiotics during three different early-life time windows (<6 months, 6–14 months, 15–23 months), and indices of body mass at five time points (6 weeks, 10 months, 20 months, 38 months and 7 years).

Results:

 

Antibiotic exposure during the earliest time window (<6 months) was consistently associated with increased body mass (+0.105 and +0.083 s.d. unit, increase in weight-for-length Z-scores at 10 and 20 months, P<0.001 and P=0.001, respectively; body mass index (BMI) Z-score at 38 months +0.067 s.d. units, P=0.009; overweight OR 1.22 at 38 months, P=0.029) in multivariable, mixed-effect models controlling for known social and behavioral obesity risk factors. Exposure from 6 to 14 months showed no association with body mass, while exposure from 15 to 23 months was significantly associated with increased BMI Z-score at 7 years (+0.049 s.d. units, P=0.050). Exposures to non-antibiotic medications were not associated with body mass.

Conclusions:

 

Exposure to antibiotics during the first 6 months of life is associated with consistent increases in body mass from 10 to 38 months. Exposures later in infancy (6–14 months, 15–23 months) are not consistently associated with increased body mass. Although effects of early exposures are modest at the individual level, they could have substantial consequences for population health. Given the prevalence of antibiotic exposures in infants, and in light of the growing concerns about childhood obesity, further studies are needed to isolate effects and define life-course implications for body mass and cardiovascular risks.

Keywords:

antibiotics; human microbiome; body mass; ALSPAC

Extra navigation

.

natureevents

ADVERTISEMENT